Locations:
Search IconSearch

News & Insight

prostate cancer

Lutetium-PSMA for Metastatic Prostate Cancer (Podcast)

FDA-approved therapy offers promise for patients with castrate-resistant prostate cancer

22-CNR-3083315-CQD-Hero-650×450 gaining trust
July 20, 2022/Cancer/News & Insight

Building Trust is a Matter of Life and Death

The cornerstone of a successful doctor-patient relationship

22-CNR-2977865-CQD-Hero-650×450
June 28, 2022/Cancer/News & Insight

The Subjective Nature of “Safe and Tolerable” Conclusions

Dr. Aaron Gerds argues for more balance in safety reporting

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Health care disparities
June 7, 2022/Cancer/News & Insight

Disparities Found in Funding of Cancer Research

Cancers that predominantly affect Black patients and cancers with higher mortality rates receive less funding

Magnetic resonance imaging (MRI) of the brain, brain tumor
October 28, 2021/Cancer/News & Insight

Cognitive Function Remains Stable Following Concurrent Temozolomide-based Chemoradiation Therapy in Low-Grade Gliomas

Study shows encouraging safety results in rare type of adult brain cancer

Ductal carcinoma (breast cancer) high grade.
October 27, 2021/Cancer/News & Insight

Biosignature Predicts Benefit of Adjuvant Radiotherapy in Patients With DCIS

Novel assay identifies women most likely to benefit

19-ORT-1123-Diagnostic-PET-CQD
October 26, 2021/Cancer/News & Insight

18F Fluciclovine PET CT Helps Distinguish Radiation Necrosis from Brain Tumor Progression

Study presented at ASTRO 2021 shows promise in patients treated with stereotactic radiosurgery

20-NEU-1990660-sleep-symptoms-in-health-workers-650×450
May 14, 2021/Cancer/News & Insight

Key to Work-Life Balance: Just Say No

Oncologist argues the "yes" culture of medicine leads to imbalance

BackPage 2 of 23Next

Advertisement

Ad